journal article·2016-03-22

Intracellularly Acid-Switchable Multifunctional Micelles for Combinational Photo/Chemotherapy of the Drug-Resistant Tumor

Tingting Wang, Dangge Wang, Haijun Yu, Mingwei Wang, Jianping Liu, Bing Feng, Fangyuan Zhou, Qi Yin, Zhiwen Zhang, Yongzhuo Huang, Yaping Li

ACS Nano· Volume 10· Issue 3
Publisher page

Abstract

The intrinsic or acquired drug resistance is the main challenge for cancer chemotherapy today. So far, many nanosized drug delivery systems (NDDS) have been exploited to combat cancer drug resistance. However, the therapy efficacy of current NDDS is severely impaired by the limited tumor penetration of the nanoparticles due to the existence of physiological and pathological barriers in the solid tumor. In this study, we report on the design and fabrication of intracellularly acid-switchable multifunctional micelles for combinational photo- and chemotherapy of the drug-resistant tumor. The micelles were composed of a pH-responsive diblock copolymer, a photosensitizer, and a polymeric prodrug of doxorubicin. The micelle displayed silenced fluorescence and photoactivity during the blood circulation and switched to an active state in weakly acid conditions (i.e., pH ≤ 6.2) in the endocytic vesicles to dramatically induce a 7.5-fold increase of the fluorescence signal for fluorescence imaging. Upon near-infrared (NIR) laser irradiation, the micelle induced notable reactive oxygen species generation to trigger cytosol release of the chemotherapeutics and perform photodynamic therapy (PDT). Moreover, the micelle efficiently converted the NIR light to local heat for enhancing tumor penetration of the anticancer drug, tumor specific photothermal therapy, and photoacoustic (PA) imaging. Furthermore, the micelles could generate amplified magnetic resonance (MR) signal in an acidic microenvironment to perform MR imaging. Collectively, this study presents a robust nanoplatform for multimodal imaging and combinational therapy of the drug-resistant tumor, which might provide an insight for developing polymer-based NDDS for cancer therapy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Photodynamic Therapy Research Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China

Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai 200032, China

Funding

Ministry of Science and Technology of the People's Republic of China · Youth Innovation Promotion Association of the Chinese Academy of Sciences · National Natural Science Foundation of China

References (46)

Show source-provided references
1. 10.1038/nmat379210.1038/nmat3792 ↗
2. 10.1021/cr300213b10.1021/cr300213b ↗
3. 10.1016/j.jconrel.2015.09.02910.1016/j.jconrel.2015.09.029 ↗
4. 10.1038/nrd274210.1038/nrd2742 ↗
5. 10.1038/nnano.2011.16610.1038/nnano.2011.166 ↗
6. 10.1038/nrclinonc.2010.13910.1038/nrclinonc.2010.139 ↗
7. 10.1038/nrc225510.1038/nrc2255 ↗
8. 10.1038/nrc70610.1038/nrc706 ↗
9. 10.1038/nrc329710.1038/nrc3297 ↗
10. 10.1016/j.cbpa.2003.08.00710.1016/j.cbpa.2003.08.007 ↗
11. 10.1021/ja052337c10.1021/ja052337c ↗
12. 10.1002/adma.20150022910.1002/adma.201500229 ↗
13. 10.1038/nnano.2013.30210.1038/nnano.2013.302 ↗
14. 10.1021/acsnano.5b0107710.1021/acsnano.5b01077 ↗
15. Paulus M. J. · Lab Animal · 2001 · 30 · 36
16. 10.1021/ar800255q10.1021/ar800255q ↗
17. 10.1021/nn502950t10.1021/nn502950t ↗
18. 10.1039/C4CS00345D10.1039/C4CS00345D ↗
19. 10.1038/ncomms571210.1038/ncomms5712 ↗
20. 10.1002/adma.20130092910.1002/adma.201300929 ↗
21. 10.1038/ncomms683410.1038/ncomms6834 ↗
22. 10.1021/ja511420n10.1021/ja511420n ↗
23. 10.1021/ja505315810.1021/ja5053158 ↗
24. 10.1021/ja410828710.1021/ja4108287 ↗
25. 10.1021/ar200223210.1021/ar2002232 ↗
26. 10.1038/793310.1038/7933 ↗
27. 10.1002/anie.20110380610.1002/anie.201103806 ↗
28. 10.1038/nmat381910.1038/nmat3819 ↗
29. 10.1021/ja207150n10.1021/ja207150n ↗
30. 10.1021/nn503349g10.1021/nn503349g ↗
31. 10.1002/adma.20150150210.1002/adma.201501502 ↗
32. 10.1038/nmat377610.1038/nmat3776 ↗
33. 10.1021/nn203503h10.1021/nn203503h ↗
34. 10.1002/adfm.20140448410.1002/adfm.201404484 ↗
35. 10.1016/S1572-1000(04)00007-910.1016/S1572-1000(04)00007-9 ↗
36. 10.1021/mp500298q10.1021/mp500298q ↗
37. 10.1039/c3py00849e10.1039/c3py00849e ↗
38. 10.1002/anie.20140013310.1002/anie.201400133 ↗
39. 10.1073/pnas.070239310410.1073/pnas.0702393104 ↗
40. 10.1016/j.actbio.2014.12.00110.1016/j.actbio.2014.12.001 ↗
41. 10.1021/acsnano.5b0053210.1021/acsnano.5b00532 ↗
42. 10.1021/nn400418y10.1021/nn400418y ↗
43. 10.1021/jacs.5b0092210.1021/jacs.5b00922 ↗
44. 10.1002/adma.20140387710.1002/adma.201403877 ↗
45. 10.1039/c3nr01025b10.1039/c3nr01025b ↗
46. 10.1021/nn900649v10.1021/nn900649v ↗